| 0 (0%) | 10-06 07:31 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 29.48  |
1-year : | 34.43 |
| Resists | First : | 25.23 |
Second : | 29.48 |
| Pivot price | 25.14 |
|||
| Supports | First : | 25.04 |
Second : | 24.93 |
| MAs | MA(5) : | 25.2 |
MA(20) : | 25.11 |
| MA(100) : | 25.08 |
MA(250) : | 0 | |
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 90.7 |
D(3) : | 91 |
| RSI | RSI(14): 60.6 |
|||
| 52-week | High : | 25.23 | Low : | 24.53 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ HAPR ] has closed below upper band by 22.2%. Bollinger Bands are 25.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 25.28 - 25.4 | 25.4 - 25.51 |
| Low: | 24.91 - 25.05 | 25.05 - 25.16 |
| Close: | 25.01 - 25.22 | 25.22 - 25.4 |
Wed, 29 May 2024
The chromosome-level genome assembly of the dwarfing apple interstock Malus hybrid ‘SH6’ - Nature.com
Fri, 05 Apr 2024
This Week in ETFs: Innovator Adds 3 New ETFs - ETF Trends
Wed, 13 Mar 2024
Genetic identification and expression optimization of a novel protease HapR from Bacillus velezensis - Frontiers
Thu, 08 Feb 2024
Regulatory Hierarchies Controlling Virulence Gene Expression in Shigella flexneri and Vibrio cholerae - Frontiers
Fri, 25 Aug 2023
Activation of a Vibrio cholerae CBASS anti-phage system by quorum sensing and folate depletion - American Society for Microbiology
Thu, 08 Dec 2022
An RNA sponge controls quorum sensing dynamics and biofilm formation in Vibrio cholerae - Nature.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|